Completely agree. This comes down to efficacy on covid. If it is shown that Leronlimab is a hands down better alternative to present treatments and the FDA does not respond favorably then and only then can a conclusion to be drawn about corruption. And like it has already been said it will be very difficult to justify to the American public that a foreign country is receiving this treatment and Americans are not. Either way for the short term it all comes down to the release of this data.